Skip to main content
Envío gratis en todos los pedidos
888-559-3802
Volver
VitabaseIngredientes

diamina oxidasa

Condiciones de Salud17
Tabla de contenidos

Otros Nombres

ABP1amiloride-binding proteinamiloride-binding protein 1amiloride-sensitive amine oxidase [copper-containing]amine oxidase (copper-containing)amine oxidase copper domain-containing protein 1amine oxidase, copper-containing, 1amine:oxygen oxidoreductase (deaminating) (pyridoxal-containing)AOC1copper amine oxidaseDAOdiamine oxidase, copper/topa quinone containingEC 1.4.3.22EC 1.4.3.6histaminasehistamine dehydrogenasehistamine oxidasehistamine:oxygen oxidoreductase (deaminating)KAOkidney amine oxidasemethylputrescine oxidaseN-methylputrescine oxidase

Sinopsis

Relora® es una mezcla herbal patentada y estandarizada desarrollada para ayudar a manejar el estrés, reducir los niveles de cortisol y promover el bienestar emocional. Está compuesta de extractos de dos plantas medicinales tradicionales: Magnolia officinalis (corteza) y Phellodendron amurense (corteza), ambas utilizadas durante mucho tiempo en la Medicina Tradicional China (TCM). Fabricado por NPI, una empresa especializada en fórmulas naturales de salud patentadas, Relora® ha sido estudiado clínicamente por sus efectos adaptogénicos, particularmente en personas con alto estrés, ansiedad o alimentación inducida por el estrés.

La formulación está diseñada para modular el eje hipotalámico-hipofisario-adrenal (HPA), el sistema responsable de gestionar las respuestas al estrés y la producción de cortisol. Los estudios clínicos muestran que Relora® puede ayudar a reducir el cortisol elevado, la "hormona del estrés" que, cuando está crónicamente alta, puede provocar fatiga, aumento de peso abdominal, irritabilidad, sueño deficiente e inmunidad suprimida. También parece mejorar el estado de ánimo y disminuir la ansiedad sin los efectos sedantes o de formación de hábito asociados con los ansiolíticos farmacéuticos.

Los compuestos activos clave en la fórmula incluyen honokiol y magnolol de Magnolia officinalis, que exhiben acciones ansiolíticas, neuroprotectoras y antiinflamatorias, y berberina de Phellodendron amurense, que contribuye con propiedades antioxidantes, antimicrobianas y reguladoras del metabolismo. Estos compuestos juntos crean un efecto sinérgico que apoya un sistema nervioso más calmado y equilibrado y respuestas fisiológicas al estrés reducidas.

Las aplicaciones modernas de Relora® frecuentemente incluyen apoyo para el exceso de alimentación relacionado con el estrés, ansiedad leve, cambios de humor relacionados con el SPM y fatiga. Generalmente es bien tolerado y no sedante, lo que lo hace adecuado para el uso diurno y los planes de manejo del estrés a largo plazo.

Uso Histórico
Aunque Relora® en sí mismo es una innovación moderna, sus componentes—Magnolia officinalis y Phellodendron amurense—tienen raíces profundas en el herbalismo del Asia Oriental, particularmente en la Medicina Tradicional China (TCM).

Magnolia officinalis (llamada Hou Po en chino) ha sido utilizada durante siglos para mover el Qi, reducir la ansiedad, calmar la mente y aliviar el malestar digestivo. A menudo se incluye en fórmulas para el estrés, el insomnio, la hinchazón y la opresión en el pecho debida a la tensión emocional.

Phellodendron amurense (conocida como Huang Bai) es una hierba amarga y refrescante utilizada tradicionalmente para eliminar el calor, secar la humedad y reducir la inflamación, frecuentemente en infecciones del tracto urinario, problemas gastrointestinales y afecciones de la piel. También desempeña un papel secundario en la regulación emocional en la TCM, especialmente cuando el estancamiento hepático o digestivo contribuye a la irritabilidad o la inquietud.

La combinación de estas dos hierbas en Relora® refleja un enfoque integrativo moderno, tomando la sabiduría herbal antigua y refinándola a través de la extracción estandarizada y la validación clínica. La fórmula surgió a principios de la década de 2000 a medida que creció el interés en alternativas naturales basadas en evidencia para manejar el estrés crónico y la desregulación del eje HPA.

Condiciones de Salud

Condiciones de salud que diamina oxidasa puede ayudar a apoyar.

  • DislocaciónCientífico

    Abdominal pain and bloating are cardinal gastrointestinal symptoms of histamine intolerance due to DAO deficiency, documented across multiple clinical cohorts. DAO supplementation trials consistently report significant reduction in abdominal pain and related GI discomfort. Histamine's contractile effect on intestinal smooth muscle is the primary mechanism.

  • Abuso y TraumaCientífico

    DAO deficiency is associated with reduced capacity to degrade histamine, which is the principal mediator of allergic rhinitis and related respiratory allergy symptoms. Clinical studies show that lower DAO activity correlates with reduced nasal airflow in persistent allergic rhinitis patients. DAO supplementation has been reported to reduce respiratory symptom scores in histamine intolerance (HIT) clinical trials.

  • Intestinal mucosal DAO activity is significantly reduced in inflamed Crohn's disease tissue compared to healthy margins, and serum DAO is investigated as a biomarker of disease activity and intestinal barrier integrity. DAO is not used as a treatment for Crohn's disease but serves as a marker of enterocyte damage and mucosal integrity.

  • Diarrhea is one of the most frequently documented gastrointestinal symptoms in histamine intolerance due to DAO deficiency. Clinical trials of DAO supplementation show significant improvement in diarrhea and loose stool in deficient patients. Serum DAO levels are inversely correlated with gastrointestinal symptom severity.

  • IndigestiónCientífico

    DAO is itself a digestive enzyme produced by mature small intestinal enterocytes, and its activity level is a direct indicator of small intestinal mucosal health and enzyme-producing cell integrity. Conditions damaging the intestinal mucosa reduce DAO activity, and DAO measurement is used clinically to assess the functional state of digestive enzyme-producing cells.

  • Síndrome de DownCientífico

    Diamine oxidase (DAO) is the primary enzyme responsible for metabolizing ingested histamine in the gastrointestinal tract. DAO deficiency is the central mechanism of histamine intolerance, a common food sensitivity. An open-label pilot study (NCT03298568) in 28 patients with histamine intolerance found oral DAO supplementation significantly reduced all 22 assessed symptoms. DAO supplementation is the most targeted therapeutic approach for histamine-related food sensitivity.

  • Diamine oxidase (DAO) is the primary intestinal enzyme responsible for degrading dietary histamine, and its deficiency is the main mechanism behind histamine intolerance—a form of food sensitivity. Randomized clinical trials show DAO supplementation taken before meals significantly reduces gastrointestinal discomfort, headache, and other histamine-mediated symptoms. A crossover RCT also demonstrated that DAO supplementation reduces migraine incidence in patients with DAO deficiency.

  • Huesos RotosCientífico

    Headache is one of the most recorded symptoms of histamine intolerance and DAO deficiency. Multiple clinical studies link low DAO activity to headache burden, and DAO supplementation has been shown to reduce headache duration in randomized trials. Histamine triggers headache through nitric oxide release and neurogenic inflammation.

  • Diamine oxidase (DAO) is the principal intestinal enzyme for degrading dietary histamine. Reduced DAO activity is considered the primary mechanism underlying histamine intolerance (HIT). An open-label pilot study (n=28) showed oral DAO supplementation before meals significantly reduced all HIT-related symptoms over 4 weeks, with symptom scores returning when supplementation stopped. A subsequent observational study (n=82) confirmed similar findings.

  • PulgasCientífico

    IBS symptom profiles heavily overlap with histamine intolerance from DAO deficiency, and some evidence suggests elevated DAO activity levels in IBS patients correlate with disease severity. DAO deficiency is one mechanism linking histamine dysregulation to IBS-like presentations, and HIT is a recognized diagnostic confounder of IBS.

  • FlotadoresCientífico

    Both Crohn's disease and ulcerative colitis within IBD are associated with reduced intestinal mucosal DAO activity, and serum DAO is studied as a biomarker of small intestinal permeability and mucosal integrity in IBD patients. Low DAO in IBD reflects enterocyte damage and can contribute to secondary histamine intolerance.

  • DAO activity reflects the integrity and maturation of the small intestinal mucosa, making serum DAO a validated biomarker of increased intestinal permeability (leaky gut). Excessive histamine accumulation from DAO deficiency can disrupt tight junction proteins, worsening intestinal permeability in a bidirectional relationship.

  • GastritisCientífico

    Diamine oxidase (DAO) is the primary enzyme responsible for degrading histamine in the GI tract. DAO deficiency is directly implicated in histamine accumulation central to MCAS and histamine intolerance. DAO enzyme supplements (primarily from porcine kidney extract) taken before meals have been studied in clinical trials for histamine-intolerance symptom reduction, and are specifically listed by the Mast Cell Action charity as relevant for MCAS management.

  • GlaucomaCientífico

    DAO deficiency is significantly more prevalent in migraine patients than in healthy volunteers, and a randomized double-blind trial demonstrated that DAO supplementation reduced migraine headache duration by approximately 1.4 hours in DAO-deficient patients. Histamine promotes migraine via nitric oxide release from H1 receptor stimulation on intracranial arteries.

  • Nausea and vomiting are recognized gastrointestinal manifestations of histamine intolerance related to DAO deficiency. Clinical classification of HIT symptoms includes vomiting, and DAO supplementation trials report improvements in GI symptom composites that include nausea. Histamine acts on gut H1/H2 receptors and the vomiting center to trigger these symptoms.

  • CallosCientífico

    Urticaria (hives) and skin rashes are well-documented cutaneous manifestations of DAO deficiency and histamine intolerance. A 30-day double-blind placebo-controlled trial demonstrated that DAO supplementation reduced urticaria activity scores and antihistamine use in patients with low DAO levels. Low serum DAO correlates with cutaneous symptom frequency in observational cohorts.

  • SIBO is associated with reduced DAO levels due to bacterial damage to small intestinal villi, and simultaneously increases luminal histamine production, creating a reinforcing cycle of DAO deficiency and histamine intolerance. Serum DAO is lower in patients with SIBO than those without, as documented in clinical studies.

Sistemas Corporales

Sistemas corporales que diamina oxidasa puede ayudar a apoyar.

  • No hay sistemas corporales disponibles.
Únete a nuestro boletín

Mantente informado. Mantente saludable.

Recibe consejos de suplementos de expertos, descuentos exclusivos y recomendaciones de productos en tu bandeja de entrada

diamina oxidasa | Vitabase